The 8 most recent market catalysts affecting $CRON, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 5, 2026
Corporate Catalyst
Bullish
Impact 92
Cronos Group Reports 2026 Third Quarter Financial Results
Cronos Group announced record financial results for the third quarter of 2026, including net revenue, gross profit, and Adjusted EBITDA. This performance was fueled by significant …
Oct 24, 2026
Corporate Catalyst
Neutral
Impact 55
Cronos Group CEO Comments on Dutch Cannabis Legalization Requirements
Cronos Group's CEO provided an assessment of the Dutch cannabis market, highlighting the current infrastructure's inadequacy for full legalization and specifying the need for addit…
Oct 13, 2026
Corporate Catalyst
Neutral
Impact 65
Zuanic & Associates Initiates Coverage On Cronos Group with Overweight Rating
Zuanic & Associates, an analyst firm, has initiated coverage on Cronos Group (CRON) with an 'Overweight' rating. This event is significant because new analyst coverage, especially …
Oct 6, 2026
Corporate Catalyst
Neutral
Impact 95
Transcript: Cronos Group Q2 2026 Earnings Conference Call
Cronos Group's Q2 2026 earnings call transcript reveals record financial results, including a 58% year-over-year increase in net revenue and a 96% increase in gross profit. This st…
Sep 28, 2026
Corporate Catalyst
Bullish
Impact 55
TD Securities Maintains Buy on Cronos Group, Raises Price Target to C$7
TD Securities analyst Derek Lessard has maintained a 'Buy' rating on Cronos Group and raised the price target from C$6 to C$7. This action signals continued confidence from a promi…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 75
Cronos Group shares are trading higher after the company reported better-than-expected Q2 financial results.
Cronos Group's outperformance in Q2 is a significant corporate catalyst, indicating potential operational improvements and stronger demand within the cannabis sector. This positive…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 92
Cronos Group Q2 EPS $0.09 Beats $0.01 Estimate, Sales $53.007M Beat $44.200M Estimate
Cronos Group's Q2 results show a significant beat on both EPS and sales estimates, with EPS at $0.09 against an expected $0.01 and sales at $53.007M against an expected $44.200M. T…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.